Related Experiment Video
Updated: Sep 19, 2025
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Identifying Environmental Factors Associated with Significant Fibrosis in Metabolic Dysfunction-Associated Steatotic
Alejandra Paredes-Marin1,2,3, Julia Napoli1, Vikram Sivakumar1,3
1Icahn School of Medicine at Mount Sinai, 1425 Madison Ave, 11-70, Box 1123, New York, NY, 10029, USA.
Background And Aim:
The role of specific environmental and socioeconomic factors associated with significant liver fibrosis in a diverse, multi-ethnic population is underexplored. We leveraged the Mount Sinai Metabolic dysfunction-associated steatotic liver disease/steatohepatitis (MASLD/MASH) Center of Excellence Longitudinal Registry and publicly available data to explore this association.
Methods:
Four hundred sixty-three New York City residents (aged 5-90) who were enrolled in the Mount Sinai MASLD/MASH Center of Excellence Longitudinal Registry were stratified for fibrosis stages using Vibration-controlled transient elastography (F0/1: < 8 kPa, F2: 8-10 kPa, F3: 10-14, F4: > 14 kPa). Using both univariable and multivariable logistic regression analyses, the association was evaluated between health disparities/environmental factors as defined by NYC.gov data (income, air quality, high school graduation rate, and access to parks and education per community district tabulation area) and significant fibrosis (kPa > 8).
Results:
Of the 422 adult and 41 pediatric eligible patients, 38% had significant fibrosis (kPa > 8), with the highest mean liver stiffness score found in Staten Island (15.8 kPa) and the lowest in Manhattan (8.9 kPa). The intersection of air pollution and obesity was evident in patients with a BMI over 30 kg/m2 living in high-air-pollution areas (> 7 PM2.5), having nearly double the odds of significant fibrosis (OR 1.85, 95% CI (1.11, 3.09)). No association between lower income and increased fibrosis was observed. Among non-Hispanics, education access was linked to significantly lower odds of fibrosis (OR 0.96, 95% CI (0.927, 1.00)). In adults, alcohol (AUDIT-C score) was associated with lower risk of significant fibrosis (OR 0.75, 95% CI (0.61, 0.92)).
Conclusion:
Understanding the interaction of health disparities, environmental risk factors, and liver fibrosis in MASLD informs both mechanistic translational studies as well as targeted population screening strategies.
More Related Videos
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Related Concept Videos
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
01:24Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:24Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:30Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...